(Q34052949)

30 July 2017

title

Design and statistical issues of the hemodialysis (HEMO) study (English)

1 reference

30 July 2017

0 references

Greene T

1

1 reference

30 July 2017

Beck GJ

2

1 reference

30 July 2017

Gassman JJ

3

1 reference

30 July 2017

Gotch FA

4

1 reference

30 July 2017

Kusek JW

5

1 reference

30 July 2017

Levey AS

6

1 reference

30 July 2017

Levin NW

7

1 reference

30 July 2017

Schulman G

8

1 reference

30 July 2017

Eknoyan G

9

1 reference

30 July 2017

language of work or name

English

0 references

publication date

1 October 2000

1 reference

Contemporary Clinical Trials

30 July 2017

published in

1 reference

30 July 2017

volume

21

1 reference

30 July 2017

issue

5

1 reference

30 July 2017

page(s)

502-525

1 reference

Five-year survival for end-stage renal disease patients in the United States, Europe, and Japan, 1982 to 1987.

30 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2800%2900062-3

7 January 2021

Changing risk factor demographics in end-stage renal disease patients entering hemodialysis and the impact on long-term mortality.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2800%2900062-3

7 January 2021

Effect of the hemodialysis prescription of patient morbidity: report from the National Cooperative Dialysis Study

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2800%2900062-3

7 January 2021

A mechanistic analysis of the National Cooperative Dialysis Study (NCDS)

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2800%2900062-3

7 January 2021

Effects of dose of dialysis on morbidity and mortality

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2800%2900062-3

7 January 2021

Urea index and other predictors of hemodialysis patient survival

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2800%2900062-3

7 January 2021

Survival of hemodialysis patients in the United States is improved with a greater quantity of dialysis

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2800%2900062-3

7 January 2021

The dose of hemodialysis and patient mortality

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2800%2900062-3

7 January 2021

Causes, kinetics and clinical implications of post-hemodialysis urea rebound

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2800%2900062-3

7 January 2021

Hemodialysis urea rebound: the effect of increasing dialysis efficiency

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2800%2900062-3

7 January 2021

Lessons from the Hemodialysis (HEMO) Study: an improved measure of the actual hemodialysis dose

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2800%2900062-3

7 January 2021

Comparison of methods to predict equilibrated Kt/V in the HEMO Pilot Study.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2800%2900062-3

7 January 2021

Amino acid and albumin losses during hemodialysis

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2800%2900062-3

7 January 2021

Improved lipid profiles in patients undergoing high-flux hemodialysis

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2800%2900062-3

7 January 2021

beta 2-Microglobulin amyloidosis: effect of ESRF treatment modality and dialysis membrane type

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2800%2900062-3

7 January 2021

Advanced glycosylation end products in patients with diabetic nephropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2800%2900062-3

7 January 2021

Generation and removal of anaphylatoxins during hemofiltration with five different membranes

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2800%2900062-3

7 January 2021

Effect of dialysis membranes and middle molecule removal on chronic hemodialysis patient survival

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2800%2900062-3

7 January 2021

Death risk in hemodialysis patients: the predictive value of commonly measured variables and an evaluation of death rate differences between facilities

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2800%2900062-3

7 January 2021

The urea reduction ratio and serum albumin concentration as predictors of mortality in patients undergoing hemodialysis

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2800%2900062-3

7 January 2021

Malnutrition in hemodialysis patients

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2800%2900062-3

7 January 2021

A hypothesis: the protein catabolic rate is dependent upon the type and amount of treatment in dialyzed uremic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2800%2900062-3

7 January 2021

Overestimation of hemodialysis dose depends on dialysis efficiency by regional blood flow but not by conventional two pool urea kinetic analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2800%2900062-3

7 January 2021

Survival as an index of adequacy of dialysis

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2800%2900062-3

7 January 2021

Assessing the adequacy of dialysis

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2800%2900062-3

7 January 2021

Functional status and quality of life: predictors of early mortality among patients entering treatment for end stage renal disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2800%2900062-3

7 January 2021

The MOS 36-ltem Short-Form Health Survey (SF-36)

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2800%2900062-3

7 January 2021

Development of the kidney disease quality of life (KDQOL) instrument.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2800%2900062-3

7 January 2021

The quality of life of hemodialysis and transplant patients

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2800%2900062-3

7 January 2021

Hemodialyzer mass transfer-area coefficients for urea increase at high dialysate flow rates. The Hemodialysis (HEMO) Study.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2800%2900062-3

7 January 2021

Statistical problems in the reporting of clinical trials. A survey of three medical journals.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2800%2900062-3

7 January 2021

Cox's Regression Model for Counting Processes: A Large Sample Study

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2800%2900062-3

7 January 2021

Dose of hemodialysis and survival: differences by race and sex.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2800%2900062-3

7 January 2021

Body weight-for-height relationships predict mortality in maintenance hemodialysis patients

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2800%2900062-3

7 January 2021

Random-effects models for longitudinal data

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2800%2900062-3

7 January 2021

An approximate generalized linear model with random effects for informative missing data

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2800%2900062-3

7 January 2021

10.1016/S0197-2456(00)00062-3

Identifiers

DOI

1 reference

30 July 2017

1 reference